Renal ischemia-reperfusion injury (IRI) after kidney transplantation is a major cause of delayed graft function. Even though IRI is recognized as a highly coordinated and specific process, the pathways and mechanisms through which the innate response is activated are poorly understood. In this study, we used a mouse model of acute kidney IRI to examine whether the interactions of costimulatory receptor CD137 and its ligand (CD137L) are involved in the early phase of acute kidney inflammation caused by IRI. We report here that the specific expressions of CD137 on natural killer cells and of CD137L on tubular epithelial cells (TECs) are required for acute kidney IRI. Reverse signaling through CD137L in TECs results in their production of the chemokine (C-X-C motif) receptor 2 ligands CXCL1 and CXCL2 and the subsequent induction of neutrophil recruitment, resulting in a cascade of proinflammatory events during kidney IRI. Our findings identify an innate pathogenic pathway for renal IRI involving the natural killer cell-TECneutrophil axis, whereby CD137-CD137L interactions provide the causal contribution of epithelial cell dysregulation to renal IRI. The CD137L reverse signaling pathway in epithelial cells therefore may represent a good target for blocking the initial stage of inflammatory diseases, including renal IRI.
Renal ischemia-reperfusion injury (IRI) after kidney transplantation is a major cause of delayed graft function. Even though IRI is recognized as a highly coordinated and specific process, the pathways and mechanisms through which the innate response is activated are poorly understood. In this study, we used a mouse model of acute kidney IRI to examine whether the interactions of costimulatory receptor CD137 and its ligand (CD137L) are involved in the early phase of acute kidney inflammation caused by IRI. We report here that the specific expressions of CD137 on natural killer cells and of CD137L on tubular epithelial cells (TECs) are required for acute kidney IRI. Reverse signaling through CD137L in TECs results in their production of the chemokine (C-X-C motif) receptor 2 ligands CXCL1 and CXCL2 and the subsequent induction of neutrophil recruitment, resulting in a cascade of proinflammatory events during kidney IRI. Our findings identify an innate pathogenic pathway for renal IRI involving the natural killer cell-TECneutrophil axis, whereby CD137-CD137L interactions provide the causal contribution of epithelial cell dysregulation to renal IRI. The CD137L reverse signaling pathway in epithelial cells therefore may represent a good target for blocking the initial stage of inflammatory diseases, including renal IRI.
acute inflammation | costimulatory ligand A cute inflammation can be induced by tissue damage caused by trauma, ischemia, and ischemia-reperfusion (1-3). Tolllike receptors (TLRs) have been implicated in recognizing a number of endogenous molecules released from injured cells and triggering acute inflammatory events (2, 3) . The development of renal ischemia-reperfusion injury (IRI) requires the expression of TLR2 and TLR4 in the tubular epithelium, its major site for cell injury (4, 5) . TLR activation may result in the secretions of specific cytokines and chemokines and alteration of cell-surface-displayed molecules in tubular epithelial cells (TECs) (6, 7) . In combination, these molecules play a crucial role in the inflammatory cascade, setting up an inflammatory loop between tubular epithelial cells and inflammatory cells (8) . However, regulation of the initial signals that recruit leukocytes following IRI is not well understood. Damaged TECs seem to contribute to the initial recruitment of neutrophils, key effectors for IRI, into kidneys by secreting C-X-C motif (CXC) chemokines (9) (10) (11) (12) (13) . Increased production of CXC chemokines in TECs during IRI may occur via three distinctive pathways: (i) as a secondary reaction in response to proinflammatory cytokines such as IL-1β and TNF-α, whose production is stimulated by the endogenous pathways leading to activation of inflammasomes, hypoxia-inducible factor 1 (HIF-1), and/or reactive oxygen species (ROS) (14) ; (ii) as a direct response to mediators released by inflammatory cells [e.g., complementary products (9) , endogenous TLR2 and TLR4 ligands (4, 5) , and proinflammatory cytokines (8) ]; and (iii) via immune cell-surface moieties that have inflammation-initiating receptors on the epithelial cell surfaces (e.g., CD40 ligand and CD40) (15).
Recent studies suggest that CD137-CD137 ligand (CD137L) interactions may participate in multiple stages of inflammation (16) (17) (18) (19) (20) (21) (22) . During antigen presentation and T-cell proliferation, CD137L on antigen-presenting cells (APCs) can costimulate CD137 on Th1 helper T cells, acting as a master regulator for the classical inflammatory pathway. In addition to this late inflammatory response, CD137 signals have been implicated in early inflammatory response-mediated innate immunity cells such as natural killer (NK) or NK T cells and granulocytes (23) (24) (25) (26) (27) . CD137L is expressed mainly on myeloid cells, including professional APCs such as macrophages and dendritic cells, and these cells can be activated by CD137L engagement to secrete cytokines and chemokines (28) (29) (30) . This CD137L reverse-signaling transduction pathway is thought to be essential in the amplification loop for inflammation. CD137 and CD137L signals also play a role in inflammation of nonhematopoietic cells such as endothelial cells (22) . CD137 and CD137L signals thus appear to have broad control over inflammation, a conclusion also supported by the CD137L-mediated control of myelopoiesis (31) , which may reflect the need for sufficient numbers of inflammatory cells during acute inflammation (32, 33) . At present, however, there is no direct in vivo evidence linking the expressions of CD137 and CD137L to discrete afferent signals such as injury sensing.
The aim of this study was to determine the specific step at which CD137-CD137L interactions regulate renal IRI-induced inflammation. We found that CD137 on NK cells specifically stimulated CD137L on TECs in such a way that TECs produced high levels of CXC chemokines required for neutrophil chemotaxis. These results indicate that via bidirectional signaling CD137 and its ligand play an indispensible role in a broad range of immune responses.
processes, but the extent to which they contribute to acute inflammation in vivo is unknown. Here we investigated the consequence of CD137-CD137L interactions during the development of acute kidney inflammation. First, we examined the expression of CD137L on kidney cells before and 4 h after induction of kidney IRI. FACS analysis showed that epithelial cell adhesion molecule (Ep-CAM)-positive TECs constitutively expressed CD137L, and the expression levels changed modestly after induction of IRI (Fig. 1A) . Immunohistochemical staining analysis also confirmed the dominant expression of CD137L in cytokeratin-positive TECs of normal and IRI kidneys (Fig. 1A) .
Following 24-h reperfusion, CD137 −/− mice showed significant decreases in plasma creatinine and blood urea nitrogen (BUN), tubular necrosis, and overall acute tubular injury in kidneys compared with those of WT mice (Fig. S1 A-D) . The protective effect observed in CD137 −/− mice correlated with less severe inflammation with poor CD45 + CD11b + Gr-1 hi neutrophil infiltration (Fig. S1B ) and lower mRNA levels of proinflammatory cytokines and chemokines (Fig. S1E) . Because infiltration of neutrophils was severely impaired in CD137 −/− mice, we predicted that the levels of neutrophil chemotactic factors would not increase in the absence of CD137-CD137L interactions in kidneys following IRI. Indeed, our immunohistochemical analysis for CXC receptor (CXCR) ligand 1 (CXCL1) and ligand 2 (CXCL2), the potent chemoattractants for neutrophils in renal IRI (34) , showed that the production of CXCL1 was detected routinely in TECs 4 h after the induction of kidney IRI (Fig. 1B) . At this time point, CXCL1 was stained much more intensely than was CXCL2 in TECs. In contrast, staining for both CXCL1 and CXCL2 was not evident in TECs of CD137 −/− or CD137L −/− kidneys (Fig. 1B) . These results suggest that CD137-CD137L interactions are required for TEC production of CXCL1 and CXCL2 during acute kidney inflammation.
To demonstrate directly that stimulation of the CD137L signaling pathway could result in the rapid production of CXCL1 and CXCL2, we triggered the CD137L signal transduction 4 per well) were cultured for 5 h in wells precoated with human IgG1 or CD137-Fc (1 μg/mL) for 5 h in the presence or absence of SB203580 (5 mM and 10 mM) or SP600125 (5 mM and 10 mM), respectively. The concentrations of CXCL1 and CXCL2 contained in the culture medium were measured using ELISA. Data are the mean ± SEM (n = 3 per group) and are representative of two to four independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001.
pathway through cell-surface engagement of CD137L with the recombinant CD137-crystallizable fragment (Fc) fusion protein. Isolated TECs secreted high levels of CXCL1 and CXCL2 within 4 h after CD137-Fc treatment (Fig. 1C) . The concentration of CXCL2 in the culture medium was fourfold lower than that of CXCL1. When conditioned medium from a culture of TECs stimulated with CD137-Fc was used for a chemotaxis assay, it was effective in inducing neutrophil migration compared with the use of conditioned medium from a culture of TECs stimulated with control human IgG1 (Fig. 1C) .
Blocking the CXCL1/CXCL2 receptor (CXCR2) with anti-CXCR2 mAb completely abrogated the increased chemotactic effect on neutrophils of conditioned medium from a culture of TECs stimulated with CD137-Fc (Fig. 1C) . The observation that anti-CXCR2 mAb had no influence on neutrophil migration induced by conditioned medium of TECs stimulated with control human IgG1 was expected, because this medium contained low levels of CXCL1 and CXCL2. Taken together, these data suggest that conditioned medium of TECs stimulated with CD137-Fc induces greater neutrophil migration through CXCLl and CXCL2.
To define further the mechanism by which CD137L signals control TEC production of CXCL1 and CXCL2, we investigated which intracellular signaling molecules are involved in this process. CD137-Fc increases phosphorylation of p38 and JNK kinases ( Fig. 1D ) and visibly affected the degradation rate of IκBα (Fig. 1D) . Consistent with this result, the production of CXCL1 and CXCL2 in TECs is inhibited specifically by inhibitors of p38 (SB203580) and JNK (SP600125) (Fig. 1D ).
CD137L Signals in TECs Are Required for Renal IRI. If TEC production of CXCL1 and CXCL2 as a result of CD137L stimulation could mediate kidney IRI, we predicted that delivery of CD137L signals would restore kidney IRI in CD137 −/− mice. We treated CD137
−/− mice with CD137-Fc to cross-link the cellsurface CD137L molecules and examined kidney function and pathology after IRI. Engagement of CD137L during renal IRI significantly increased neutrophil recruitment into kidneys and exacerbated renal IRI (Fig. 2 A-D) . This result indicated that triggering the CD137L signaling pathway was sufficient to initiate an inflammatory response in kidneys in response to ischemiareperfusion, even in the absence of CD137 signals. In addition, we found that CD137-Fc further increased kidney IRI in WT mice ( Fig. 2 E-H). When we administered agonistic anti-CD137 mAb i.v. into WT mice 1 h before ischemia, mice that received anti-CD137 mAb showed significantly reduced renal IRI as compared with mice that received control rat IgG (Fig. S2) . These results indicate that CD137 stimulation has a minimal effect on renal IRI. Rather, treatment with anti-CD137 mAb may inhibit renal IRI by blocking the CD137L signaling pathway. Collectively, these data clearly demonstrate the causal relationship between CD137L signals and neutrophil recruitment and the subsequent inflammatory immune response in kidneys after IRI.
To demonstrate directly that CD137L signals in TECs are a prerequisite for renal IRI, we devised an experimental system in which signaling through CD137L in TECs was allowed in CD137L −/− mice. To do so, we implanted WT TECs under the kidney capsule of CD137L −/− mice, induced renal IRI immediately after implantation, and examined kidney function and pathology 24 h after IRI. We implanted WT TECs into WT mice as a positive control and CD137L
−/− TECs into mice of the same genotype as a negative control. Ischemia-reperfusion significantly increased creatinine and BUN levels in CD137L
−/− mice and in WT mice that were implanted with WT TECs as compared with the levels in CD137L
−/− mice that were implanted with CD137L
−/− TECs (Fig. 3A) . Consistent with this finding, implantation of WT TECs into CD137L
−/− and WT mice induced heavier recruitment of neutrophils into kidneys than did implantation of CD137L −/− TECs into CD137L −/− mice ( Fig.  3B ). Histological analysis showed that neutrophils infiltrated not only into the subcapsular space containing WT TECs but also into the kidney outer medulla and cortex of CD137L −/− and WT mice that were implanted with WT TECs; tissue damage in these areas was evident (Fig. 3C ). This broader pattern of kidney damage was characteristic of the implanted mice, whereas tissue damage in unimplanted WT mice was mainly in the outer medulla. Implantation of CD137L −/− TECs into CD137L −/− mice was not accompanied by neutrophil migration or tissue damage, as was seen in the other two groups of mice ( Fig. 3 C and D) . Data are the mean ± SEM from six to eight mice per group in two independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001.
Overall, the severity of kidney IRI in CD137L −/− mice that received WT TECs was not significantly different from that in WT mice that received WT TECs but was significantly higher than that in CD137 −/− mice that received CD137 −/− TECs (Fig. 3D ). Taken together, our results clearly demonstrate that expression of CD137L on TECs is required for kidney IRI.
CD137 on NK Cells Stimulates CD137L on TECs to Produce CXCL1 and CXCL2 for Neutrophil Chemotaxis. The data presented so far suggest that cross-linking of CD137L on TECs with CD137 produces CXCL1 and CXCL2 and that these chemokines in turn recruit neutrophils into kidneys after IRI. As an initial step to identify which CD137-expressing cells could stimulate TEC CD137L, we investigated whether hematopoietic cells contributed to the in vivo differences in reperfusion injury observed between WT and CD137 −/− mice. We treated mice of both genotypes with total body irradiation followed by transplantation with bone marrow (BM) from the opposite genotype. WT and CD137
−/− mice also were reconstituted with BM from mice with the same genotype and were used as controls. We used genomic PCR analysis to confirm that hematopoietic cells were replaced by the donor genotypes in WT → CD137 −/− and CD137 −/− → WT mice 10 wk after BM transfer (Fig. S3A) . Mice then were subjected to 35-min renal ischemia followed by 24-h reperfusion. CD137 −/− → WT mice showed reduced renal IRI, as seen in the CD137 −/− → CD137 −/− chimeras ( Fig. S3 B-E) . In contrast, renal IRI of WT → CD137 −/− chimeras was evident and comparable to that in WT → WT chimeras (Fig. S3 B-E) . Our results clearly demonstrated that the resistance of CD137 −/− mice to kidney IRI resulted from CD137 deficiency in hematopoietic cells.
Because TECs produce high levels of CXCL1 and CXCL2 at an early time after IRI induction, we examined which cells express CD137 in kidneys 4 h after renal IRI. We found that CD137 is expressed on NK cells infiltrated into kidneys (Fig. 4A) . At this time point, the expression of CD137 was not detected on CD4 + T cells, B cells, macrophages,, or neutrophils, and its expression levels were low on NK T cells and dendritic cells (Fig.  S4) . We could not analyze CD137 expression on CD8 + T cells in kidneys 4 h after IRI, because their number was so small. Immunohistochemical analysis showed that the basement layers surrounding the tubular epithelium were severely destroyed as early as 4 h after renal IRI and that some NK cells were in contact with TECs (Fig. 4B) .
Next, we wanted to demonstrate directly that CD137-CD137L interactions between NK cells and TECs resulted in the production of CXCL1 and CXCL2 by TECs in the NK cell/TEC coculture system. We activated WT, CD137L
−/− , and CD137 −/− TECs to produce high levels of CXCL1 and CXCL2 (Fig. 4 B and C) . In contrast, activated CD137 −/− NK cells failed to stimulate production of CXCL1 and CXCL2 in either WT or CD137L −/− TECs (Fig. 4D ). Cells were cocultured with TECs at the ratio of 5:1 for 4 h, and culture medium was harvested. CXCL1 and CXCL2 levels in the culture medium were quantified using ELISA. (E) Cocultured cells were harvested and stained with anti-CXCL1 and anti-cytokeratin mAbs. (Magnification: 20×.) (F) Conditioned medium of NK cell/TEC cocultures was used for chemotaxis assay. Data are the mean ± SEM (n = 3 per group) and are representative of two independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001.
producing CXCL1 and CXCL2 were cytokeratin-positive (Fig.  4E) , confirming that they were TECs. In a chemotaxis assay, conditioned medium of WT or CD137L
−/− NK cell/WT TEC cocultures induced higher neutrophil migration through CXCR2 than was induced by conditioned medium of WT or CD137L
−/− TEC cocultures (Fig. 4F) . There was no difference in the neutrophil migration induced by conditioned medium of CD137 −/− NK cell/WT TEC versus that in CD137
−/− NK cell/CD137L −/− TEC coculture (Fig. 4F) . These results are consistent with the data presented in Fig. 1C, again suggesting that the concentrations of CXCL1 and CXCL2 in conditioned medium are important for determining neutrophil migration. When these results are taken together, our in vitro system clearly demonstrates that NK cells contribute to renal IRI by rendering TECs capable of promoting the production of high levels of CXCL1 and CXCL2 through CD137L signals. −/− mice in the number of infiltrating NK cells (Fig. 5A) , and the transferred NK cells infiltrated into kidneys 4 h after renal IRI (Fig. S5) (Fig. 6) , confirming that NK cells are required for neutrophil recruitment after IRI induction. Depletion of neutrophils also abrogated the development of kidney IRI (Fig. 7) . These results suggested that neutrophils might have been the major cell type responsible for tissue damage during kidney IRI, rather than NK cells, whose main function seemed to be to recruit neutrophils (35) . We wanted to confirm further that NK cells induce the production of CXCL1 and CXCL2 in vivo in TECs using the TEC implantation system. NK cells were detected in the subcapsular space containing live TECs 4 h after IRI induction in WT → WT, WT → CD137L −/− , and CD137L −/− → CD137L −/− mice (Fig.  S7) . However, CXCL1 and CXCL2 levels in the subcapsular space of CD137L −/− → CD137L −/− mice were very low compared with those in the other two groups of mice (Fig. S7) . At this time point, neutrophil numbers already correlated positively with levels of CXCL1 and CXCL2 in the subcapsular space.
Discussion
The acute phase of renal IRI is believed to be initiated by the innate immune response as a result of trauma caused by renal mice is sufficient to restore kidney IRI to the extent as seen in WT mice (Fig. 4) ; (ii) implantation of WT TECs into the CD137L −/− kidney subcapsule recovers kidney IRI (Fig. 3) ; (iii) production of CXCL1 and CXCL2 is induced in TECs after the influx of NK cells in the TEC implantation model (Fig. S6) ; and (iv) depletion of NK cells impairs neutrophil recruitment (Fig.  6) , and kidney IRI does not occur in the absence of neutrophils (Fig. 7) . However, we cannot exclude the possibility that CD137-CD137L interactions in other types of cells could contribute to renal IRI.
In ischemic acute kidney injury, hypoxic and anoxic cell injuries occur early during the ischemic phase (37) . Injured cells that undergo necrosis may produce so-called "endogenous inducers of inflammation" such as ATP, uric acid, heat-shock proteins, and high-mobility group box 1 protein (2). TLR2 and TLR4 on TECs function as sensors for endogenous inducers of inflammation and play roles in the production of cytokines and chemokines and neutrophil infiltration (4, 5, 38, 39) . This study demonstrated a significant decrease in neutrophil influx in CD137 −/− mice following kidney IRI, similar to that in TLR2 −/− or TLR4 −/− mice. Activation of TLR2 or TLR4 on TECs initiates an inflammatory response characterized by the recruitment of leukocytes, including neutrophils, to the sites of injury by a tightly controlled sequence of events. Because recruitment of CD137 −/− NK cells after kidney IRI is normal (Fig. 5A) , the impairment of neutrophil recruitment in CD137 −/− mice should lie downstream of TLR signals, more specifically after influx of NK cells and before neutrophil recruitment following kidney IRI. Indeed, our results clearly demonstrate that CD137 −/− NK cells failed to induce recruitment of neutrophils because of their inability to stimulate TECs to produce CXCL1 and CXCL2 during kidney IRI. Therefore, we concluded that the CD137-CD137L axis provided by NK cell-TEC interactions is responsible for the main influx of neutrophils in the amplification loop of inflammation during kidney IRI. An important remaining issue is the identity of any TEC-secreted chemokines that mediate the recruitment of NK cells following TLR activation.
It has become clear that NK cells interact with various components of the immune system and therefore have the potential to function as regulatory cells (40) . NK cells can influence the immune response through their ability to kill either immune or target cells, secrete IFN-γ, and act directly on T and B cells (41) . NK cells can either suppress or enhance the adaptive immune response depending upon the context. Zhang and colleagues have provided compelling evidence for the involvement of NK cells in kidney IRI (35, 42) . In their models, the interactions of NKG2D receptor on NK cells and Rae-1 on TECs play important roles in NK cell-mediated perforin-dependent TEC killing (35) . TECs function not only as target cells for NK cells but also as regulators to recruit and activate NK cells by secreting osteopontin after kidney IRI (42) . Our results indicate that NK cells play an additional key regulatory role as amplifiers of inflammation (i.e., stimulated TEC-dependent enhancement of neutrophil recruitment) during kidney IRI. Even though we could not exclude the possibility that the interactions of CD137 on NK cells and CD137L on TECs involved NK cell-mediated TEC killing (Fig. S8) , tissue damage after kidney IRI appeared to be caused by neutrophil recruitment after CD137L stimulation. This conclusion was based on the following in vivo and in vitro observations: (i) although CD137 stimulation is implicated in NK cell activation (43) , agonistic anti-CD137 mAb blocked rather than promoted kidney IRI (Fig. S2); (ii) CD137-Fc completely recovered kidney IRI in CD137 −/− mice that were resistant to kidney IRI (Fig. 2) ; (iii) stimulation of the CD137L signaling pathway in TECs induced the production of high levels of neutrophil chemokines; and (iv) NK cells were critical in neutrophil recruitment (Fig. 6) , and kidney IRI was not induced in the absence of neutrophils (Fig. 7) .
Here we demonstrate that CD137/CD137L interactions between immune cells (NK cells) and parenchymal cells (TECs) propagate tissue inflammation through the activation of parenchymal cells in a disease context. It is surprising that CD137L signals in TECs, rather than CD137 signals in NK cells, are critical in amplifying inflammation, given previous reports that CD137 signals either enhance NK-cell effector function (cytotoxic ability and cytokine production) directly (23) or play a role in NK-cell-mediated activation or differentiation of conventional T cells (44) . It is noteworthy that CD137L also has been shown to regulate the sustained production of TNF-α in macrophages via a complex with TLRs in a CD137-independent manner (45) . However, the resistance of both CD137 −/− and CD137L −/− mice to lipopolysaccharide shock (23, 45) suggests the existence of a CD137-dependent mechanism for production of proinflammatory cytokines and inflammatory responses. Consistent with this hypothesis, stimulation of the CD137L signaling pathway induced the production of proinflammatory cytokines in various cells such as macrophages (Fig. S9) . However, in TECs, signaling through CD137L resulted in the production of chemokines but not proinflammatory cytokines (Fig.  S10) . These data suggest that CD137L signals may regulate tissue inflammation in a cell type-specific manner. An understanding of the properties of tissue inflammation therefore will require investigation of the spatiotemporal expressions of CD137 and CD137L (46) , currently underway in our laboratory.
Agonistic CD137-specific mAbs suppress disease in mouse models of autoimmune encephalomyelitis (47), asthma (48), arthritis (18) , systemic lupus erythematosus (49, 50) , and graftversus-host disease (51, 52) . A consensus on how stimulation of CD137 prevents disease has yet to emerge, but CD137 appears to be involved in the hyperactivation of T cells, causing them to acquire regulatory capacity or induce cell death. Our results suggest another explanation for the immunosuppressive activity of anti-CD137 mAbs: They can inhibit inflammatory responses by blocking the CD137L signaling pathway under certain circumstances. The immunosuppressive effects of anti-CD137 mAbs may be most prominent in the context of inflammation involving robust antigen-specific adaptive immune responses involving CD8 + T cells, CD4 + T cells, and Ig (53) . Because anti-CD137 mAbs efficiently prevent kidney IRI, pharmacological interventions aimed at neutralization of CD137L activity may act as a prophylactic approach for renal failure, which commonly occurs in kidney transplantation.
In summary, our results demonstrate that activation of the CD137L signaling pathway in TECs plays a critical regulatory role in kidney IRI. Pharmacological inhibition of CD137L activation suggests a strategy for preventing renal failure in transplanted kidneys.
Materials and Methods

Mice. CD137
−/− mice have been described (54) and were backcrossed to BALB/c and C57BL/6 mice for at least 12 generations (55). CD137L −/− mice (56) were backcrossed eight times to C57BL/6 mice (45). All mice were maintained in a specific pathogen-free facility and were used between 7 and 8 wk of age. WT BALB/c and C57BL/6 mice were purchased from Orient. Animal studies were approved by the University of Ulsan Animal Care and Use Committee.
Antibodies and Reagents. Cells or tissue sections were stained with fluorescent-or biotin-conjugated mAbs that specifically recognize CD3, CD11b, CD45, CD122, CD137, CD137L, CXCL1, CXCL2, cytokeratin, DX5 (CD49b), Ep-CAM, Gr-1, and NK1.1 (eBioscience). Rabbit anti-laminin polyclonal and goat anti-rabbit IgG-FITC (Abcam), anti-cytokeratin-FITC (Sigma-Aldrich), and anti-phycoerythrin antibodies (Santa Cruz) were purchased and used for staining. The following antibodies raised against signaling molecules were used for immunoblot: p38, phosphorylated p38 (p-p38), ERK, p-ERK, JNK, p-JNK (all from Cell Signaling), and IkBα (Santa Cruz). Anti-GAPDH antibodies were purchased from Millipore. The following kinase inhibitors were purchased from Abcam: PD98059, SB203580, and SP600125. For in vivo administration, anti-CD137 (3E1) and anti-Gr-1 (RB6-8C5) mAbs were produced from ascites. Anti-NK1.1 (PK136) mAbs were purchased from e-Bioscience. Rat IgG and human IgG 1 were purchased from Sigma-Aldrich and used as controls.
Production of Recombinant CD137-Fc Fusion Protein. The murine CD137-Fc fusion construct was generated in the following manner: DNA encoding the signal peptide sequence and the extracellular domain (amino acids 1-76) was generated by PCR using a forward primer containing a Hind III site (CD137F) (5′-AAG CTT ATG GGA AAC AAC TGT-3′) and a reverse primer (CD137R) (5′-ACA AGA TCT GGG CTC TGG AGT CAC-3′). DNA containing human IgG1 Fc region was generated using a forward primer (FcF) (5′-GTG ACT CCA GAG CCC AGA TCT TGT-3′) and a reverse primer containing a Xho I site (FcR) (5′-CTC GAG TCA TTT ACC CGG AGA-3′). A second round of PCR was performed using the CD137F and FcR primer set and the CD137 DNA fragment and the Fc DNA fragment as templates. The CD137-Fc fusion DNA was cloned into the pd18 vector (57) . The CD137-Fc construct was stably transfected into CHO cells using a Gene Pulser electroporation apparatus (Bio-Rad) at 960 μF and 250 V. Multiple rounds of gene amplification were performed as previously described (58) . The CD137-Fc protein was affinity purified on protein G according to the manufacturer's instructions (Invitrogen). Purified proteins were dialyzed three times against PBS (pH 7.4) and filter-sterilized through 0.2-μm syringe filter units (Millipore).
Induction of Renal IRI. Renal IRI was induced as previously described (59) . In brief, following anesthesia, bilateral flank incisions were performed, both kidney arteries were exposed and cross-clamped for 35 min, and reperfusion was allowed for 24 h through clamp release. A sham operation was performed using the same surgical procedure without clamping the renal artery. During the surgery, mice were placed on a 37°C heat pad. In some experiments, anti-CD137 mAb (200 μg per mouse) or CD137-Fc (50 μg per mouse) was injected into the tail vein 1 h before ischemia. The same amounts of rat IgG or human IgG1 were used as controls for anti-CD137 or CD137-Fc, respectively. For in vivo depletion of NK cells or neutrophils, anti-NK1.1 (200 μg per mouse) or anti-Gr-1 mAb (250 μg per mouse) was administered 24 h before IRI induction. Rat IgG was used as a control for these experiments.
Preparation of Kidney Cells. Kidneys were perfused, minced, and placed in DMEM containing 1 mg/mL collagenase IA (Sigma Aldrich) at 37°C for 30 min. Digested kidney tissues were passed through a 100-μm cell strainer (BD Falcon) using the rubber end of a 1-mL syringe plunger, and a cell suspension was obtained via centrifugation at 300 × g for 10 min. Analysis of Renal Function. Kidney function was determined by measuring creatine and BUN concentrations in sera obtained 24 h after kidney IRI.
Creatine and BUN concentrations were measured colorimetrically using the Quantichrom Urea Assay kit and the Quantichrom Creatine Assay kit, respectively, according to the manufacturer's instructions (Bioassay Systems).
Histochemistry. Kidneys were fixed in 10% (vol/vol) formalin, paraffin-embedded, and sectioned (5 μm). Paraffin sections were stained with H&E and analyzed. Kidney injury was scored by a single pathologist (H.J.C.) for the percentage of damaged tubules in the corticomedullary junction. Criteria for kidney injury included tubular necrosis, cast formation, loss of brush border, tubular dilatation, and immune cell infiltration. Scoring was as follows: 0, no change; 1, <10%; 2, 11-25%; 3, 25-45%; 4, 46-75%; 5, >76% area change.
RT-PCR. Total RNA was isolated from frozen kidneys with TRIzol (Invitrogen) and used to generate first-strand cDNA using a Power cDNA Synthesis kit (iNtRON Biotechnology). The first-strand cDNA was amplified via PCR using a pair of the specific upstream and downstream primers. Primer sequences were as follows: C-C chemokine receptor type 1 (CCR1): 5′-CTCTTCCTGTTC-ACGCTTCC-3′ (forward) and 5′-CCAAATGTCTGCTCTGCTCA-3′ (reverse); C-C chemokine receptor type 2 (CCR2): 5′-AACTCCTGCCTCCGCTCTAC: -3′ (forward) and 5′-TCACTGCCCTATGCCTCTTC-3′ (reverse); chemokine (C-C motif) ligand 2 (CCL2): 5′-CTGCCCTTGCTGTCCTCCTCTG-3′ (forward) and 5′-CTGC-CGGCTTGCTTGGTTA-3′ (reverse); CCL3: 5′-CACTCACTCCACAACCCAAGA-3′ (forward) and 5′-CAAAGACCCTCAAAACATCCC-3′ (reverse); TNF-α: 5′-GTTCT-ATGGCCCAGACCCTCACA-3′ (forward) and 5′-TCCCAGGTATATGGGCTCA-TACC-3′ (reverse); TGF-β: 5′-CAACAATTCCTGGCGTTACCTTGG-3′ (forward) and 5′-GAAAGCCCTGTATTCCGTCTCCTT-3′ (reverse); CXCL1: 5′-CTTGAAGG-TGTTGCCCTCAG-3′ (forward) and 5′-TGGGGACACCTTTTAGCATC-3′ (reverse); GAPDH: 5′-TGATGACATCAAGAAGGTGGTGAAG-3′(forward) and 5′-TCCTTG-GAGGCCATGTGGGCCAT-3′(reverse). Implantation of TECs. Three-passage TECs were harvested and resuspended in methylcellulose medium (StemCell Technologies). TECs (2 × 10 5 cells in 10 μL of medium) then were implanted beneath the kidney capsule.
ELISA. The concentrations of CXCL1 and CXCL2 in the culture supernatant were measured using the Quantikine ELISA kit, according to the manufacturer's instructions (R&D Systems).
Neutrophil Isolation and Chemotaxis Assay. Neutrophils were isolated from the BM using anti-Gr-1 microbeads (Miltenyi Biotec) as previously described. Flow cytometry was used to confirm that the purity of Gr-1 + cells was greater than 95%. Chemotaxis assays were performed using the GCMTM Chemotaxis Assay kit, according to the manufacturer's instructions (Millipore). In brief, purified neutrophils were plated (5 × 10 5 per well) in Transwell inserts (Costar) containing 3-μm pores. Conditioned medium was added to the lower chamber, and the plates were incubated at 37°C for 12 h. Anti-mouse CXCR2 mAb (50 μg/mL) was used to neutralize neutrophil-surface CXCR2 (R&D Systems). The cell suspension from the lower chamber was transferred into a 96-well plate and stained with WST-1 solution (Millipore) at 37°C for 30 min. The absorbance of samples was measured using a microplate reader at 450 nm.
Immunohistochemistry. Kidneys were embedded in OCT compound (Sakura) and frozen in liquid nitrogen. Frozen sections (8 μm thick) were permeabilized with 0.3% (vol/vol) Triton X-100, and nonspecific binding was blocked with 10% (vol/vol) donkey serum and anti-mouse CD16/CD32 mAbs (10 μg/mL). Sections were labeled with the relevant Abs for 1 h at room temperature. All specimens were mounted with Prolong Antifade reagent (Molecular Probes). Slides were examined under a laser-scanning confocal microscope (Olympus).
Immunoblot. Three-passage TECs (1 × 10 5 per well) were transferred into a six-well plate precoated with CD137-Fc protein (1 μg/mL) overnight and resuspended. Cells were harvested at the indicated times after the transfer and resuspended in 50 μL of lysis buffer [25 mM Tris·HCl (pH 7.4), 50 mM NaCl, 0.5% (wt/vol) sodium deoxycholate, 2% (vol/vol) Nonidet P-40, 0.2% (wt/vol) SDS, 1 mM phenylmethylsulfonyl fluoride, 50 μg/mL aprotinin, 50 μM leupeptin, and 0.5 mM Na 3 VO 4 ] on ice for 30 min followed by centrifugation at 400 × g for 15 min. Lysates (5 μg) were resolved by 10% (wt/vol) SDS/PAGE. Proteins were transferred electrophoretically to nitrocellulose membranes. Membranes were blocked with 5% dry milk in PBS followed by exposure to primary antibodies and subsequent secondary antibodies conjugated to HRP (Santa Cruz Biotechnology). Immunoreactive bands were visualized using the ECL kit (Amersham Biosciences).
Statistics. GraphPad Prism 4 (GraphPad Inc.) was used to analyze and present the data. Differences between groups were analyzed using a twotailed t test or one-or two-way ANOVA with post hoc analysis, as appropriate. Values are expressed as the mean ± SEM. P < 0.05 was considered statistically significant.
